ANIKA FFRENCH: Open Payments
NPI 1528806684 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,307 in 41 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $269 · 2025 $1,307
Food & beverage: $1,196Education: $111
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $402 |
| Neurocrine BioSciences, Inc. | 6 | $261 |
| Alkermes, Inc. | 9 | $230 |
| Teva Pharmaceuticals USA, Inc. | 4 | $173 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| Axsome Therapeutics, Inc. | 1 | $84 |
| Lundbeck LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: INVEGA SUSTENNA, INGREZZA, LYBALVI, ARISTADA, REXULTI, Auvelity, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across DE — which companies pay providers there.
